Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NanoSight nanoparticle detection technique contributes to virus production to counter MRSA

SEM image of staphylococcus aureus
SEM image of staphylococcus aureus

Abstract:
Virus particle detection and counting using Nanoparticle Tracking Analysis is providing essential information for researchers at the University of Strathclyde's Institute of Pharmacy and Biomedical Sciences (SIPBS). This team develops methods to employ naturally-occurring bacteriophages to combat MRSA and other bacteria. MRSA - or Methicillin resistant Staphylococcus aureus - is a variation of the bacterium Staphylococcus aureus, which has developed resistance to most antibiotics, making it difficult to treat and potentially deadly. Whilst the "Superbug" can be killed with detergents, detergent dilution and application is often inconsistent and ineffective, hence the bacteriophage route.

NanoSight nanoparticle detection technique contributes to virus production to counter MRSA

UK | Posted on December 9th, 2008

It is in characterizing bacteriophage cultures that NanoSight comes into play, employed within a team lead by Dr Mike Mattey, honorary lecturer at SIPBS. Prior to deploying bacteriophages as a dry-coat, to protect high-risk bacterial invasion sites (sutures, instruments and wounds), the cultures need characterization and their concentration needs assessing. NanoSight allows the team to view and size viral cultures rapidly, in real time and at low cost.

"The characterization of virus populations requires assessment of aggregation in the 20nm - 1,000nm range" says Dr Mattey. "NanoSight provides fast and easy quantitative sample characterization not possible with other methods (such as using the Beckman Coutler DLS, plaque assay & SEM) and at a much lower cost. Additionally, NanoSight's technology provides a reassuring view of the particle population that supports the counting results".

The NanoSight LM system uses a novel employment of laser light scattering. These instruments visualize and dynamically size populations of suspended particles on an individual basis down to a particle size of approx 20nm, dependent on material. NanoSight directly tracks the Brownian motion of each and every particle separately but simultaneously using a CCD camera and from a high resolution plot of the particle size distribution profile (and changes therein in time). Aggregation and flocculation are immediately apparent. This particle-by-particle approach avoids the ensemble assumptions of dynamic light scattering (DLS) and provides a unique image, going beyond light scattering in assessing polydisperse systems and providing insight into aggregation.

####

About NanoSight Limited
NanoSight Ltd, of Salisbury, UK, is the world leading provider of instruments for the optical detection and real time analysis of sub-micron particles. The Company supplies unique instruments for nanoparticle analysis in the sub-micron region that have specific application in virus particle detection and counting. These instruments go far beyond existing light scattering techniques in characterising polydispersed systems. Founded in 2004, the company currently has over 140 systems in service worldwide, having begun commercial sales in 2006.

The Company’s proprietary knowledge and expertise has enabled the delivery of technologies to blue chip companies and universities for direct visualization of individual nanoscale particles in suspension from which independent quantitative estimation of particle size, size distribution and concentration are immediately obtained. The Company has recently launched additions to its advanced Nanoparticle Tracking Analysis (NTA) software that build on the ground-breaking work of NanoSight’s LM20 and LM10 systems.

The Company has a growing base of users worldwide, including BASF, GlaxoSmithKline, 3M Corp, BP, ICI, Roche & Unilever and many universities.

For more information, please click here

Contacts:
NanoSight Ltd.
2 Centre One,
Lysander Way,
Old Sarum Park,
Salisbury,
Wiltshire,
SP4 6BU,
United Kingdom.
Tel +44 (0)1722349439
Fax +44 (0)1722329640


USA West Coast Office
Duncan Griffiths
NanoSight USA West
3027 Madeira Ave.
Costa Mesa, CA 92626
Tel 714-747-9955


USA East Coast Office
Jim Munhall
NanoSight East Coast Office
6660 N. High Street
Suite 2A
Worthington, Ohio 43085
Tel (614) 987-0045
Fax (614) 888-0025
Cell (614) 264-3493

Copyright © NanoSight Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Imaging

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Nanomedicine

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Announcements

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Tools

Carbon nanodots do an ultrafine job with in vitro lung tissue: New experiments highlight the role of charge and size when it comes to carbon nanodots that mimic the effect of nanoscale pollution particles on the human lung. September 12th, 2018

Terahertz spectroscopy enters the single-molecule regime September 7th, 2018

Mirrorcle Demonstrates MEMS-based Programmable Light Source at CES and PW18 August 30th, 2018

Stress-free ALD from Picosun August 28th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project